RESEARCH &RELATED Other Project Information 6. Project Summary/Abstract The development of cardiac hypertrophy, the most common precursor to heart failure, is a response of the heart to a wide range of extrinsic stimuli, including hypertension, valvular heart disease, and myocardial infarction. Parallel impairment in fatty acid oxidation and an increase in glucose utilization occur during this process, regulated primarily by the peroxisome proliferator-activated receptor (PPAR) family of transcription factors. The mechanism(s) that regulates this decrease in PPAR transcription factor activity during the development of cardiac hypertrophy is presently unknown. In this proposal, we will first identify the mechanism(s) by which the cardiac specific Muscle Ring Finger-1 (MuRF1) ubiquitinates the PPAR- complex, targeting its proteasome-dependent degradation. These findings will then be confirmed in vivo using our established MuRF1 -/- and MuRF1 cardiac transgenic mouse lines. The role of MuRF1 expression on PPAR-regulated fatty acid and glucose oxidation will then be determined by detecting oxidation metabolites from isolated working heart preparations perfused with radio-labeled fatty acid and glucose. In the second aim of this study, we will determine the signaling pathways which regulate increases in cardiac MuRF1 during cardiac hypertrophy, focusing on NF-B, FOXO, and FAK/MAPK signaling pathways. We will then determine how pressure overload affects MuRF1 and PPAR- activity and localization in cardiac hypertrophy, to elucidate the mechanisms by which MuRF1 interacts and regulates PPAR-, or other components of the PPAR- complex. Lastly, we will elucidate specific mechanisms by which pressure overload induces changes in fatty acid and glucose oxidation by linking the mechanical stretch of cardiomyocytes to increases in MuRF1.
In specific aim three, we will demonstrate the mechanisms by which stretch increases MuRF1 activity by its up-regulation of MuRF1 levels transcriptionally and through the stretch-induced translocation of MuRF1 from the sarcomere into the cytoplasm and nucleus. We will then determine how MuRF1 interacts with nuclear PPAR- during mechanical stretch to regulate fatty acid and glucose oxidation through the mechanisms identified in specific aim #1 (MuRF1 ubiquitination of PPAR- and subsequent degradation by the proteasome) and specific aim #2 (how stretch regulates MuRF1 levels through NF- kB and FOXO signaling pathway). These studies will identify for the first time how mechanical stress from a variety of cardiac pathologies leads to characteristic changes in fatty acid and glucose oxidation through the titin-associated ubiquitin ligase MuRF1. .
RESEARCH &RELATED Other Project Information and Project Narrative. Heart failure is a leading cause of death in the United States, affecting approximately 5.2 million people, with an approximately 60,000 new cases diagnosed each year, costing an estimated $33.2 billion in 2007. While significant changes in metabolism occur during the development of heart failure and its most common precursor cardiac hypertrophy, the underlying mechanisms that regulate these changes are not clearly delineated. Elucidating these novel mechanisms as proposed in this study will help identify targets for the development of therapies for this common disease.
|Willis, Monte S; Holley, Darcy Wood; Wang, Zhongjing et al. (2017) BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility. J Mol Cell Cardiol 105:99-109|
|Jensen, Brian C; Bultman, Scott J; Holley, Darcy et al. (2017) Upregulation of autophagy genes and the unfolded protein response in human heart failure. Int J Clin Exp Med 10:1051-1058|
|Jensen, Brian C; Parry, Traci L; Huang, Wei et al. (2017) Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis. Br J Pharmacol 174:4797-4811|
|Abdullah, Muhammad; Berthiaume, Jessica M; Willis, Monte S (2017) Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all. Transl Res :|
|Files, D Clark; Ilaiwy, Amro; Parry, Traci L et al. (2016) Lung injury-induced skeletal muscle wasting in aged mice is linked to alterations in long chain fatty acid metabolism. Metabolomics 12:|
|Wadosky, Kristine M; Berthiaume, Jessica M; Tang, Wei et al. (2016) MuRF1 mono-ubiquitinates TR? to inhibit T3-induced cardiac hypertrophy in vivo. J Mol Endocrinol 56:273-90|
|Quintana, Megan T; Parry, Traci L; He, Jun et al. (2016) Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 Signaling. Am J Pathol 186:1989-2007|
|Brown, David I; Cooley, Brian C; Quintana, Megan T et al. (2016) Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic Dysfunction. Int J Pept Res Ther 22:317-324|
|Parry, Traci L; Willis, Monte S (2016) Cardiac ubiquitin ligases: Their role in cardiac metabolism, autophagy, cardioprotection and therapeutic potential. Biochim Biophys Acta 1862:2259-2269|
|Parry, Traci L; Desai, Gopal; Schisler, Jonathan C et al. (2016) Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1. Cardiovasc Pathol 25:127-140|
Showing the most recent 10 out of 73 publications